# Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis

Study · id `cardio:ct-nct07307989` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07307989](<https://clinicaltrials.gov/study/NCT07307989>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07307989

Browse, organ or system: Brain; Metabolism  
Browse, condition area: Risk and prevention; Stroke; Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT07307989. Randomized; single masking; primary purpose treatment. Start 2025-08-01 (actual); primary completion 2029-07-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT07307989, source copy `cardio:ctgov-nct07307989-2025-12-30`, retrieved 2026-10-26)
- Started: 2025-08-01 (actual) (ClinicalTrials.gov record NCT07307989, source copy `cardio:ctgov-nct07307989-2025-12-30`, retrieved 2026-10-26)
- Primary completion: 2029-07-31 (anticipated) (ClinicalTrials.gov record NCT07307989, source copy `cardio:ctgov-nct07307989-2025-12-30`, retrieved 2026-10-26)
- Completion: 2029-07-31 (anticipated) (ClinicalTrials.gov record NCT07307989, source copy `cardio:ctgov-nct07307989-2025-12-30`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT07307989, source copy `cardio:ctgov-nct07307989-2025-12-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07307989-2025-12-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis
- Condition: Ischemic Stroke
- Condition: Hypercholesteremia
- Intervention (Drug): statin + ezetimibe
- Intervention (Drug): Statin monotherapy (rosuvastatin or atorvastatin)
- Lead sponsor: Chang Gung Memorial Hospital
- Lead sponsor class: OTHER
- Collaborator: Chang Gung University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry condition terms include this condition: High cholesterol (hypercholesterolemia) (`cardio:hypercholesterolemia`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Chang Gung Memorial Hospital (`cardio:org-chang-gung-memorial-hospital`)

## Provenance

Content hash: b61e762663e7c223ff48e154695008608925ece746cb7629ed2957066d3d717b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
